Concentrations of 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with intracranial hypertension.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid; D002551:Cerebral Ventricle Neoplasms / Q000134:cerebrospinal fluid; D002559:Cerebrospinal Fluid Rhinorrhea / Q000134:cerebrospinal fluid; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006259:Craniocerebral Trauma / Q000134:cerebrospinal fluid; D003704:Dementia / Q000134:cerebrospinal fluid; D004827:Epilepsy / Q000134:cerebrospinal fluid; D005260:Female; D005910:Glioma / Q000134:cerebrospinal fluid; D006801:Humans; D006849:Hydrocephalus / Q000134:cerebrospinal fluid; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D007427:Intracranial Pressure; D008297:Male; D008581:Meningitis / Q000134:cerebrospinal fluid; D008875:Middle Aged; D008881:Migraine Disorders / Q000134:cerebrospinal fluid; D009497:Neurotic Disorders / Q000134:cerebrospinal fluid; D010911:Pituitary Neoplasms / Q000134:cerebrospinal fluid; D013345:Subarachnoid Hemorrhage / Q000134:cerebrospinal fluid; D014277:Trigeminal Neuralgia / Q000134:cerebrospinal fluid
D006897:Hydroxyindoleacetic Acid